If you’re a chief financial officer at a life sciences company, you know how hard it is to pay sites.
In Tom Goodwin’s oft-quoted article in Techcrunch last year, he says “Uber, the world’s largest taxi company, owns no vehicles.
Perhaps more than any other component of a clinical trial, enrollment keeps clinical executives awake at night. Waiting for the first patient in is one of the most tension-filled aspects of the clinical research lifecycle. Since we already took a look at global enrollment trends, we decided to look at enrollment from another angle: site performance. Of course, site performance is a critical factor in the success of any